Squarepoint Ops LLC Novo Cure LTD Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$12.42 - $17.29 $3.23 Million - $4.5 Million	260,460 Added 368.28%	331,184 $5.18 Million
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $675,769 - $958,098	60,716 Added 606.67%	70,724 $1.06 Million
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $3.41 Million - $6.99 Million	-84,708 Reduced 89.43%	10,008 $415,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $5.35 Million - $11.3 Million	94,716 New	94,716 $5.7 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $1.38 Million - $1.82 Million	20,286 New	20,286 $1.54 Million
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $415,670 - $660,225	-7,344 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $1.96 Million - $2.75 Million	-32,578 Reduced 81.6%	7,344 $608,000
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $7.01 Million - $11.4 Million	-93,344 Reduced 70.04%	39,922 $3 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $7.02 Million - $11.8 Million	60,420 Added 82.94%	133,266 $15.5 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $4.16 Million - $7.2 Million	31,899 Added 77.9%	72,846 $16.2 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $2.13 Million - $3.26 Million	17,136 Added 71.97%	40,947 $5.41 Million
Q4 2020 Feb 16, 2021	BUY	$112.16 - $174.14 $1.46 Million - $2.27 Million	13,037 Added 121.0%	23,811 $4.12 Million
Q3 2020 Nov 16, 2020	SELL	$58.05 - $111.31 $10.2 Million - $19.5 Million	-175,221 Reduced 94.21%	10,774 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $10.1 Million - $13.2 Million	176,738 Added 1909.24%	185,995 $11 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $1.35 Million - $2.27 Million	-23,738 Reduced 71.94%	9,257 $623,000
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $1.53 Million - $2.1 Million	22,399 Added 211.39%	32,995 $2.78 Million
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $3.09 Million - $4.89 Million	-50,004 Reduced 82.51%	10,596 $792,000
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $977,393 - $1.46 Million	23,150 Added 61.82%	60,600 $3.83 Million
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $268,336 - $471,183	8,396 Added 28.9%	37,450 $1.8 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $21,396 - $39,209	-745 Reduced 2.5%	29,054 $973,000
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $64,832 - $106,162	2,026 Added 7.29%	29,799 $1.56 Million
Q2 2018 Aug 14, 2018	SELL	$19.85 - $32.0 $368,713 - $594,400	-18,575 Reduced 40.08%	27,773 $869,000
Q1 2018 May 15, 2018	BUY	$19.3 - $23.65 $587,048 - $719,362	30,417 Added 190.93%	46,348 $1.01 Million
Q4 2017 Feb 14, 2018	BUY	$16.3 - $21.9 $259,675 - $348,888	15,931	15,931 $322,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$205 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$200 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$134 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$72.6 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$51.1 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.77B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account